TELA Bio (TELA) Cash from Investing Activities (2018 - 2026)
TELA Bio's (TELA) quarterly Cash from Investing Activities came in at $190000.0 in Q1 2026, up 37.68% year-on-year from $138000.0 in Q1 2025, and down 1.04% quarter-over-quarter from $192000.0 in Q4 2025.
TELA Bio (TELA) Cash from Investing Activities (2018 - 2026) Analysis & Trends
TELA Bio's Cash from Investing Activities history runs 9 years deep, the most recent figure standing at $190000.0 for Q1 2026.
- On a quarterly basis, Cash from Investing Activities rose 37.68% year-over-year to $190000.0 in Q1 2026; TTM through Mar 2026 was $898000.0, a 939.25% increase from a year earlier, with the FY2025 full-year figure at $846000.0, down 80.99% from the prior year.
- Cash from Investing Activities fell to $190000.0 in Q1 2026 per TELA's latest filing, from $192000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $4.7 million in Q1 2024 and bottomed at -$1.0 million in Q4 2022.
- The 5-year median for Cash from Investing Activities is -$122000.0 (2024), against an average of $177411.8.
- Across the five-year window, Cash from Investing Activities sank 1427.27% in 2022 and surged 4183.48% in 2024, its largest moves.
- Year by year, Cash from Investing Activities stood at -$1.0 million in 2022, then surged by 81.55% to -$193000.0 in 2023, then gained by 1.55% to -$190000.0 in 2024, then soared by 201.05% to $192000.0 in 2025, then retreated by 1.04% to $190000.0 in 2026.
- Per Business Quant, the three latest TELA Cash from Investing Activities figures stand at $190000.0 (Q1 2026), $192000.0 (Q4 2025), and $312000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -298.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.50 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -475.32 Mn |
| 10 | TELA Bio | 38.36 Mn | -1.18 Mn | 12.52 Mn | 190,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 190,000.00 |
| Mar 31, 2026 | 190,000.00 |
| Dec 31, 2025 | 192,000.00 |
| Dec 31, 2025 | 192,000.00 |
| Sep 30, 2025 | 312,000.00 |
| Sep 30, 2025 | 312,000.00 |
| Jun 30, 2025 | 204,000.00 |
| Jun 30, 2025 | 204,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Mar 31, 2025 | 138,000.00 |
| Dec 31, 2024 | -190,000.00 |
| Dec 31, 2024 | -190,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Sep 30, 2024 | -122,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Mar 31, 2024 | 4.70 Mn |
| Mar 31, 2024 | 4.70 Mn |
| Dec 31, 2023 | -193,000.00 |
| Dec 31, 2023 | -193,000.00 |